Immune Therapeutics
Kelly Wilson is currently the President at Biostax Corp. and has previously held positions such as Chief Operating Officer at Murphy Advisors and Director of Corporate Program Management at Statera BioPharma, Inc. With a background in instructional design and technology, Kelly has experience working in various companies overseeing Information Technology implementation, project planning, training development, and creating online training programs. Kelly holds a Master's degree in Instructional Systems Design from the University of Central Florida.
This person is not in any offices
Immune Therapeutics
Immune Therapeutics is a specialty pharmaceutical company involved in the manufacturing, distribution and marketing of our novel patented therapies to combat chronic, life-threatening diseases through the activation and modulation of the body’s immune system.